Synonyms:D-cycloserine, cycloserine, 68-41-7, Seromycin, orientomycin, Oxamycin, Cyclo-D-serine, Cyclorin, D-4-amino-3-isoxazolidinone, Cicloserina, Farmiserina, Miroseryn, Tisomycin, Wasserina, Closina, Cycloserinum, (+)-4-Amino-3-isoxazolidinone, (R)-4-AMINOISOXAZOLIDIN-3-ONE, D-4-amino-3-isoxazolidone, alpha-Cycloserine, (4R)-4-amino-1,2-oxazolidin-3-one, Miroserina, Tebemicina, Novoserin, (+)-Cycloserine, Oxamicina, PA 94, Cycloserin, Micoserina, D-(+)-Cycloserine, (4R)-4-aminoisoxazolidin-3-one, PA-94, (R)-4-AMINO-ISOXAZOLIDIN-3-ONE, D-Oxamycin, RO-1-9213, D-CS, 3-Isoxazolidinone, 4-amino-, (R)-, E-733-A, D-4-Amino-3-isossazolidone, (R)-4-Amino-3-isoxazolidone, 3-Isoxazolidinone, 4-amino-, (4R)-, HSDB 3218, D-Oxamicina, 3-Isoxazolidinone, 4-amino-, d-, K-300, I-1431, 3-Isoxazolidinone, 4-amino-, (+)-, NSC 154851, CHEBI:40009, AI3-50153, D-Cycloserine, synthetic, CHEMBL771, SC-49088, 95IK5KI84Z, DCS, DTXSID8022870, NSC-76029, NSC-154851, CAS-68-41-7, NCGC00016306-01, Oxamicina [Italian], Cicloserina [Italian], Cycloserinum [INN-Latin], Cicloserina [INN-Spanish], DTXCID902870, Cycloserine, D-, Closerin, .alpha.-Cycloserine, MFCD00005353, (R)-Cycloserine, Seromycin (TN), SMR000058313, D-4-Amino-3-isossazolidone [Italian], R-(+)-Cycloserine, (R)-4-Amino-3-isoxazolidinone, (4R)-4-Amino-3-isoxazolidinone, CYCLOSERINE (D), SR-01000075432, DRG-0195, (R)-(+)-Cycloserine, EINECS 200-688-4, D-amino-3-isoxazolidinone, BRN 0080798, UNII-95IK5KI84Z, cycloserine-(d), Serine, cyclo-, 3-Isoxazolidinone, 4-amino-, D, R(+)-4-Amino-3-isoxazolidinone, Cycloserine [USP:INN:BAN:JAN], 4AX, 3-Isoxazolidinone, 4-amino-, (R), (R)-(+)-4-Amino-3-isoxazolidinone, Cycloserine, D(+), D-Cycloserine, powder, Spectrum_000860, 1pb9, CYCLOSERINE [MI], Prestwick0_001089, Prestwick1_001089, Prestwick2_001089, Prestwick3_001089, Spectrum2_000084, Spectrum3_000371, Spectrum4_000305, Spectrum5_000797, CYCLOSERINE [INN], CYCLOSERINE [JAN], Lopac-C-1159, Lopac-C-3909, Lopac-C-7005, CYCLOSERINE [HSDB], 3-Isoxazolidinone, 4-amino-, (4R)- (9CI), C 3909, C-9390, C-9400, CYCLOSERINE [VANDF], CYCLOSERINE [MART.], Lopac0_000252, SCHEMBL34322, BSPBio_001138, BSPBio_002121, CYCLOSERINE [WHO-DD], CYCLOSERINE [WHO-IP], KBioGR_000890, KBioSS_001340, 4-27-00-05549 (Beilstein Handbook Reference), MLS000758215, MLS001423962, MLS002548887, BIDD:GT0707, D-Cycloserine synth. BP 88, DivK1c_000098, SPECTRUM1500215, SPBio_000008, SPBio_003029, BPBio1_001252, FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09, GTPL9489, Cycloserine (JP17/USP/INN), 4-Amino-3-isoxazolidinone, D-, HMS500E20, KBio1_000098, KBio2_001340, KBio2_003908, KBio2_006476, KBio3_001341, CYCLOSERINE [ORANGE BOOK], NINDS_000098, CYCLOSERINE [USP IMPURITY], HMS1571I20, HMS1920C06, HMS2051C15, HMS2091I14, HMS2098I20, HMS2232F03, HMS3259L19, HMS3260D06, HMS3715I14, NJ-21, Pharmakon1600-01500215, CYCLOSERINE [USP MONOGRAPH], (R)-3-Isoxazolidinone, 4-amino-, 4-Amino-3-isoxazolidinone, (R)-, ACT04767, CYCLOSERINUM [WHO-IP LATIN], HY-B0030, Tox21_110361, Tox21_500252, BDBM50038178, BDBM50103516, CCG-39705, D-Cycloserine, >=96.0% (NT), LMPK14000007, NSC756712, s1998, 4-Isoxazolidinamine, 3-oxo-, (D)-, AKOS015994626, Tox21_110361_1, AC-4721, DB00260, HS-0079, LP00252, NC00050, NC00676, NSC-756712, SDCCGSBI-0050240.P005, IDI1_000098, SMP1_000167, NCGC00015213-01, NCGC00015213-02, NCGC00015213-03, NCGC00016306-02, NCGC00016306-03, NCGC00016306-04, NCGC00016306-05, NCGC00016306-07, NCGC00016306-08, NCGC00016306-17, NCGC00093713-01, NCGC00093713-02, NCGC00260937-01, CAS-339-72-0, SBI-0050240.P004, AB00443920, EU-0100252, 3-Isoxazolidinone, 4-amino-, (+)- (8CI), EN300-97131, C08057, D00877, M01471, AB00443920_09, AB00443920_10, A836140, Q418508, SR-01000759389, SR-01000075432-1, SR-01000075432-2, SR-01000075432-5, SR-01000075432-9, SR-01000759389-4, SR-01000075432-10, F2173-1228, Z1198154206, Cycloserine, United States Pharmacopeia (USP) Reference Standard, Cycloserine, Pharmaceutical Secondary Standard; Certified Reference Material, (4R)-4-azaniumyl-4,5-dihydroisoxazol-3-olate;(R)-4-AMINOISOXAZOLIDIN-3-ONE
Pubchem:PUBCHEM:449215
Id:c83a597b-f770-51e1-9fbc-794184332209
Description:nan
